Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.

Harper J, Adams KJ, Bossi G, Wright DE, Stacey AR, Bedke N, Martinez-Hague R, Blat D, Humbert L, Buchanan H, Le Provost GS, Donnellan Z, Carreira RJ, Paston SJ, Weigand LU, Canestraro M, Sanderson JP, Botta Gordon-Smith S, Lowe KL, Rygiel KA, Powlesland AS, Vuidepot A, Hassan NJ, Cameron BJ, Jakobsen BK, Dukes J.

PLoS One. 2018 Oct 15;13(10):e0205491. doi: 10.1371/journal.pone.0205491. eCollection 2018.

2.

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Cameron BJ, Gerry AB, Dukes J, Harper JV, Kannan V, Bianchi FC, Grand F, Brewer JE, Gupta M, Plesa G, Bossi G, Vuidepot A, Powlesland AS, Legg A, Adams KJ, Bennett AD, Pumphrey NJ, Williams DD, Binder-Scholl G, Kulikovskaya I, Levine BL, Riley JL, Varela-Rohena A, Stadtmauer EA, Rapoport AP, Linette GP, June CH, Hassan NJ, Kalos M, Jakobsen BK.

Sci Transl Med. 2013 Aug 7;5(197):197ra103. doi: 10.1126/scitranslmed.3006034.

3.

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.

McCormack E, Adams KJ, Hassan NJ, Kotian A, Lissin NM, Sami M, Mujić M, Osdal T, Gjertsen BT, Baker D, Powlesland AS, Aleksic M, Vuidepot A, Morteau O, Sutton DH, June CH, Kalos M, Ashfield R, Jakobsen BK.

Cancer Immunol Immunother. 2013 Apr;62(4):773-85. doi: 10.1007/s00262-012-1384-4. Epub 2012 Dec 22.

4.

Glycoproteomic characterization of carriers of the CD15/Lewisx epitope on Hodgkin's Reed-Sternberg cells.

Powlesland AS, Barrio MM, Mordoh J, Hitchen PG, Dell A, Drickamer K, Taylor ME.

BMC Biochem. 2011 Mar 24;12:13. doi: 10.1186/1471-2091-12-13.

5.

Mouse LSECtin as a model for a human Ebola virus receptor.

Pipirou Z, Powlesland AS, Steffen I, Pöhlmann S, Taylor ME, Drickamer K.

Glycobiology. 2011 Jun;21(6):806-12. doi: 10.1093/glycob/cwr008. Epub 2011 Jan 21.

6.

Engineered carbohydrate-recognition domains for glycoproteomic analysis of cell surface glycosylation and ligands for glycan-binding receptors.

Powlesland AS, Quintero-Martinez A, Lim PG, Pipirou Z, Taylor ME, Drickamer K.

Methods Enzymol. 2010;480:165-79. doi: 10.1016/S0076-6879(10)80009-6. Review.

PMID:
20816210
7.

Trimeric structure of langerin.

Feinberg H, Powlesland AS, Taylor ME, Weis WI.

J Biol Chem. 2010 Apr 23;285(17):13285-93. doi: 10.1074/jbc.M109.086058. Epub 2010 Feb 24.

8.

Targeted glycoproteomic identification of cancer cell glycosylation.

Powlesland AS, Hitchen PG, Parry S, Graham SA, Barrio MM, Elola MT, Mordoh J, Dell A, Drickamer K, Taylor ME.

Glycobiology. 2009 Aug;19(8):899-909. doi: 10.1093/glycob/cwp065. Epub 2009 May 11.

9.

Prolectin, a glycan-binding receptor on dividing B cells in germinal centers.

Graham SA, Jégouzo SA, Yan S, Powlesland AS, Brady JP, Taylor ME, Drickamer K.

J Biol Chem. 2009 Jul 3;284(27):18537-44. doi: 10.1074/jbc.M109.012807. Epub 2009 May 6.

10.

Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR.

Yu QD, Oldring AP, Powlesland AS, Tso CK, Yang C, Drickamer K, Taylor ME.

J Mol Biol. 2009 Apr 17;387(5):1075-80. doi: 10.1016/j.jmb.2009.02.046. Epub 2009 Feb 26.

11.

A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans.

Powlesland AS, Fisch T, Taylor ME, Smith DF, Tissot B, Dell A, Pöhlmann S, Drickamer K.

J Biol Chem. 2008 Jan 4;283(1):593-602. Epub 2007 Nov 5.

12.

Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins.

Powlesland AS, Ward EM, Sadhu SK, Guo Y, Taylor ME, Drickamer K.

J Biol Chem. 2006 Jul 21;281(29):20440-9. Epub 2006 May 8. Erratum in: J Biol Chem. 2006 Sep 1;281(35):25868.

Supplemental Content

Loading ...
Support Center